Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
vaminolac innrennslislyf, lausn
fresenius kabi ab - histidinum inn; phenylalaninum inn; leucinum inn; tyrosinum inn; serinum inn; lysinum inn; cysteinum inn; glycinum inn; prolinum inn; tryptophanum inn; methioninum inn; threoninum inn; isoleucinum inn; taurinum inn; acidum glutamicum inn; valinum inn; argininum inn; acidum asparticum inn; alaninum inn - innrennslislyf, lausn
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
xylocain smyrsli 50 mg/g
aspen pharma trading limited - lidocainum inn - smyrsli - 50 mg/g
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - Öll önnur lækningavörur - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
ephedrine sintetica stungulyf, lausn 50 mg/ml
sintetica gmbh - ephedrinum hýdróklóríð - stungulyf, lausn - 50 mg/ml